Alıntılar

APA (7. basım) Alıntı
Brown, S., Everett, C. C., Naraghi, K., Davies, C., Dawkins, B., Hulme, C., . . . Buch, M. H. (2018). Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: The SWITCH RCT. NIHR Journals Library.
Chicago Style (17. basım) Atıf
Brown, Sarah, et al. Alternative Tumour Necrosis Factor Inhibitors (TNFi) or Abatacept or Rituximab Following Failure of Initial TNFi in Rheumatoid Arthritis: The SWITCH RCT. NIHR Journals Library, 2018.
MLA (9th ed.) Atıf
Brown, Sarah, et al. Alternative Tumour Necrosis Factor Inhibitors (TNFi) or Abatacept or Rituximab Following Failure of Initial TNFi in Rheumatoid Arthritis: The SWITCH RCT. NIHR Journals Library, 2018.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..